Plasma protein binding rate of lofexidine was (about) 38%.
洛非西定的血浆蛋白结合率约为38%。
OBJECTIVE To study the plasma protein binding rate of harmine hydrochloride.
目的：测定盐酸去氢骆驼蓬碱的血浆蛋白结合率。
According to our results, it was concluded that the PK parameters differences between human and rat were not due to plasma protein binding.
结果表明人与大鼠药代动力学参数的差异不是由蛋白结合率的差异所导致。
Plasma protein binding influences distribution and the apparent relationship between pharmacologic activity and total plasma drug concentration.
血浆蛋白的结合作用会影响药物的分布，并影响药理活性和总血浆药物浓度间的表观关系。
Finally, the binding rate of plasma protein was determined by trichloroacetic acid precipitation.
最后用三氯醋酸法测定其血浆蛋白结合率。
CONCLUSION ESI-MS offers some advantages in sensitivity, high-speed, accuracy for studying the noncvalent binding between anti-hepatitis B immune ribonucleic acid and human plasma protein.
结论ESI-MS技术用于抗乙肝免疫核糖核酸与蛋白间的非共价结合化学计量比研究具有灵敏、快速和准确的特点。
Objective: to investigate plasma levels of insulin like growth factor 1 (IGF 1) and its binding protein 3 (IGFBP 3) in type 2 diabetes and their relationship with microangiopathy.
目的：观察2型糖尿病病人血中胰岛素样生长因子-1 (IGF - 1)及胰岛素样生长因子结合蛋白-3 (IGFBP - 3)水平与糖尿病及微血管病变的关系。
Methods: the binding rate of DCPB to plasma protein was determined by equilibrium dialysis method, and the content of CYP450 was assayed by differential spectrum method.
方法：用分光光度法测定cyp450含量，用平衡透析法测定蛋白结合率。
Methods: the binding rate of DCPB to plasma protein was determined by equilibrium dialysis method, and the content of CYP450 was assayed by differential spectrum method.
方法：用分光光度法测定cyp450含量，用平衡透析法测定蛋白结合率。
应用推荐